Literature DB >> 21781425

Acute disseminated encephalomyelitis (ADEM) after pertussis infection.

B Budan1, B Ekici, B Tatli, A Somer.   

Abstract

Acute disseminated encephalomyelitis (ADEM) is an immune-mediated demyelinating disorder of the central nervous system which is usually precipitated by a viral infection or vaccination. A 3-month-old boy is reported who developed ADEM a week after full recovery from pertussis. MRI detected a high-intensity lesion extending from the pons to the mesencephalon, compatible with ADEM. Following the administration of intravenous immunoglobulins, the patient's clinical symptoms improved. This case report demonstrates that pertussis is capable of inducing an immune-mediated demyelinating disorder of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21781425     DOI: 10.1179/1465328111Y.0000000028

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  3 in total

1.  Treatment of acute disseminated encephalomyelitis.

Authors:  Daniela Pohl; Silvia Tenembaum
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.972

2.  Cognitive Development One Year After Infantile Critical Pertussis.

Authors:  John T Berger; Michele E Villalobos; Amy E Clark; Richard Holubkov; Murray M Pollack; Robert A Berg; Joseph A Carcillo; Heidi Dalton; Rick Harrison; Kathleen L Meert; Christopher J L Newth; Thomas P Shanley; David L Wessel; Kanwaljeet J S Anand; Jerry J Zimmerman; Ronald C Sanders; Teresa Liu; Jeri S Burr; Douglas F Willson; Allan Doctor; J Michael Dean; Tammara L Jenkins; Carol E Nicholson
Journal:  Pediatr Crit Care Med       Date:  2018-02       Impact factor: 3.624

Review 3.  The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.

Authors:  Samantha E Marin; David J A Callen
Journal:  Neuroimaging Clin N Am       Date:  2013-02-26       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.